(1 - 10 von 48
)
Juventas and SironRX CEO Rahul Aras talks regenerative medicine
medcitynews.com
Regenerative medicine is the focus of two Cleveland Clinic spinoffs, Juventas and SironRX. Read an interview with the CEO of both companies, Rahul Aras.
The Alliance for Regenerative Medicine Names 32 Member...
www.wallstreet-online.de
Rahul Aras, President and CEO, Juventas Usman Azam, Global Head Cell & Gene Therapies Unit, Novartis Doug Doerfler, President & CEO, MaxCyte
BioCardia and Juventas to start phase II trial for heart failure treatmentcardiovascularnews.com › News
cardiovascularnews.com
· ... I clinical trial and is an attractive delivery system for our targeted patient population,” said Rahul Aras, president and CEO Juventas.
sironrx gets third frontier funding for clinical trials, staff growthwww.freshwatercleveland.com › sironrx
www.freshwatercleveland.com
· ... product,” explains Rahul Aras, SironRX president and CEO. “With SRX100, we accelerate treatment in dermal wounds and prevent scarring.
sortiert nach Relevanz / Datum